Genotyping of genetically monomorphic bacteria: DNA sequencing in Mycobacterium tuberculosis highlights the limitations of current methodologies.

PloS One
Iñaki ComasSebastien Gagneux

Abstract

Because genetically monomorphic bacterial pathogens harbour little DNA sequence diversity, most current genotyping techniques used to study the epidemiology of these organisms are based on mobile or repetitive genetic elements. Molecular markers commonly used in these bacteria include Clustered Regulatory Short Palindromic Repeats (CRISPR) and Variable Number Tandem Repeats (VNTR). These methods are also increasingly being applied to phylogenetic and population genetic studies. Using the Mycobacterium tuberculosis complex (MTBC) as a model, we evaluated the phylogenetic accuracy of CRISPR- and VNTR-based genotyping, which in MTBC are known as spoligotyping and Mycobacterial Interspersed Repetitive Units (MIRU)-VNTR-typing, respectively. We used as a gold standard the complete DNA sequences of 89 coding genes from a global strain collection. Our results showed that phylogenetic trees derived from these multilocus sequence data were highly congruent and statistically robust, irrespective of the phylogenetic methods used. By contrast, corresponding phylogenies inferred from spoligotyping or 15-loci-MIRU-VNTR were incongruent with respect to the sequence-based trees. Although 24-loci-MIRU-VNTR performed better, it was still unable ...Continue Reading

References

Jan 1, 1983·Journal of Molecular Evolution·M NeiY Tateno
Sep 2, 1997·Proceedings of the National Academy of Sciences of the United States of America·S SreevatsanJ M Musser
Apr 18, 1998·Proceedings of the National Academy of Sciences of the United States of America·M C MaidenB G Spratt
Jan 27, 1999·Bioinformatics·D Posada, K A Crandall
Nov 26, 1999·Proceedings of the National Academy of Sciences of the United States of America·M AchtmanE Carniel
Feb 15, 2001·Proceedings of the National Academy of Sciences of the United States of America·E MazarsP Supply
Aug 30, 2001·Journal of Clinical Microbiology·A M KlevytskaP Keim
Apr 6, 2002·Bioinformatics·Heiko A SchmidtArndt von Haeseler
Jul 16, 2002·Systematic Biology·N GoldmanA G Rodrigo
Jun 18, 2003·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Christophe SolaNalin Rastogi
Aug 13, 2003·Bioinformatics·Fredrik Ronquist, John P Huelsenbeck
Oct 8, 2003·Systematic Biology·Stéphane Guindon, Olivier Gascuel
Mar 26, 2004·Proceedings of the National Academy of Sciences of the United States of America·Aaron E HirshPeter M Small
May 21, 2004·Nature Reviews. Microbiology·Edward J Feil
Sep 7, 2004·Proceedings of the National Academy of Sciences of the United States of America·Talima PearsonPaul Keim
Oct 23, 2004·Emerging Infectious Diseases·Lucy BakerFrancis Drobniewski
Dec 8, 2004·Journal of Clinical Microbiology·Vincent RamisseGilles Vergnaud
Dec 16, 2004·Proceedings of the National Academy of Sciences of the United States of America·Mark AchtmanPaul Keim
Dec 31, 2004·International Journal of Clinical Pharmacology and Therapeutics·J BonelliM Schwarz
May 17, 2005·Science·Marc MonotStewart T Cole
Jul 8, 2005·Journal of Clinical Microbiology·Anthony G TsolakiPeter M Small
Feb 16, 2006·Proceedings of the National Academy of Sciences of the United States of America·Sebastien GagneuxPeter M Small
Mar 18, 2006·Science·Robert F Service
Oct 17, 2006·Clinical Microbiology Reviews·Barun MathemaBarry N Kreiswirth
Mar 30, 2007·Annual Review of Biomedical Engineering·Sobin Kim, Ashish Misra
Apr 24, 2007·The Lancet Infectious Diseases·Sebastien Gagneux, Peter M Small
May 10, 2007·Insect Molecular Biology·W C Black, J G Vontas
May 10, 2007·Molecular Biology and Evolution·Koichiro TamuraSudhir Kumar

❮ Previous
Next ❯

Citations

Mar 4, 2011·Future Microbiology·Midori Kato-MaedaLaura Flores
Feb 28, 2014·Proceedings. Biological Sciences·Romy MüllerTerence A Brown
Sep 2, 2014·Nature Communications·Francesc CollTaane G Clark
Oct 10, 2014·BMC Genomics·Andreas SteinerSebastien Gagneux
Mar 31, 2010·BMC Infectious Diseases·Sidra E Gonçalves VasconcellosJohn L Ho
Oct 12, 2010·PLoS Neglected Tropical Diseases·Bouke C de JongSebastien Gagneux
Feb 18, 2011·Journal of Clinical Microbiology·Anita C SchürchDick van Soolingen
Mar 23, 2011·Antimicrobial Agents and Chemotherapy·Claudio U KöserJohn A C Archer
Mar 25, 2011·Journal of Clinical Microbiology·Sema MandalIbrahim Abubakar
Apr 29, 2011·The New England Journal of Medicine·Richard W TrumanStewart T Cole
Jun 29, 2011·Antimicrobial Agents and Chemotherapy·Michaela ProjahnStefan Niemann
Sep 21, 2011·Antimicrobial Agents and Chemotherapy·Silke FeuerriegelStefan Niemann
Feb 9, 2012·The Journal of Infectious Diseases·Barun MathemaBarry N Kreiswirth
Feb 15, 2013·Journal of Clinical Microbiology·Janina DomogallaMathias Büttner
Sep 5, 2013·BMC Bioinformatics·Patrícia SoaresJosé B Pereira-Leal
Sep 7, 2013·BMC Research Notes·Bereket WorkalemahuAbraham Aseffa
Sep 21, 2013·Emerging Infectious Diseases·Florian GehreBouke C de Jong

❮ Previous
Next ❯

Methods Mentioned

BETA
Electrophoresis
genotyping
PCR
genoptyping

Software Mentioned

MEGA
MLSA
Modeltest
Bionumerics
Tree
PAUP
- Puzzle
PHYML
Tracer

Related Concepts

Related Feeds

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Buruli Ulcer

Buruli ulcer is a progressive disease of subcutaneous tissues caused by mycobacterium ulcerans. Here is the latest research.